Key result
Abstract provides no clinical data or findings.
Expert consensus on advanced HF therapies; leaves open optimal selection between transplantation and durable MCS.
aAdvanced Heart Failure, Heart Transplantation and Mechanical Circulatory Support Programs, Cardiology Division, University of Chicago, Chicago, Illinois bHeart Failure, Cardiac Mechanical Support and Cardiac Transplantation Program, Division of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah, USA Correspondence to Stavros G. Drakos, MD, PhD, University of Utah, 30. North 1900 East, Salt Lake City, UT 84132, USA. E-mail: [email protected]; Nir Uriel, MD, The University of Chicago Medicine, 5841 S. Maryland Avenue, MC 2016, Chicago, IL 60637, USA. Tel: +1 773 702 9396; fax: +1 773 834 1764; e-mail: [email protected]
No takes yet. Share an insight, caveat, or question.
Uriel et al. (2015) conducted a review in Heart failure. New therapies was evaluated. The abstract contains no clinical data or findings, only author affiliations and correspondence information.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: